Nukkleus Statistics
Total Valuation
Nukkleus has a market cap or net worth of $71.28 million. The enterprise value is $73.41 million.
Important Dates
The next estimated earnings date is Tuesday, March 25, 2025, after market close.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nukkleus has 4.79 million shares outstanding. The number of shares has increased by 37.23% in one year.
| Current Share Class | 4.79M |
| Shares Outstanding | 4.79M |
| Shares Change (YoY) | +37.23% |
| Shares Change (QoQ) | +14.27% |
| Owned by Insiders (%) | 37.35% |
| Owned by Institutions (%) | 1.12% |
| Float | 3.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.23 |
| Forward PS | n/a |
| PB Ratio | -9.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.14
| Current Ratio | 0.14 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.06 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -397.30% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 226.57% |
| Revenue Per Employee | $492,788 |
| Profits Per Employee | -$709,877 |
| Employee Count | 12 |
| Asset Turnover | 2.73 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +109.27% in the last 52 weeks. The beta is -6.40, so Nukkleus's price volatility has been lower than the market average.
| Beta (5Y) | -6.40 |
| 52-Week Price Change | +109.27% |
| 50-Day Moving Average | 19.15 |
| 200-Day Moving Average | 8.90 |
| Relative Strength Index (RSI) | 44.85 |
| Average Volume (20 Days) | 251,316 |
Short Selling Information
The latest short interest is 181,818, so 3.80% of the outstanding shares have been sold short.
| Short Interest | 181,818 |
| Short Previous Month | 220,232 |
| Short % of Shares Out | 3.80% |
| Short % of Float | 6.06% |
| Short Ratio (days to cover) | 1.13 |
Income Statement
In the last 12 months, Nukkleus had revenue of $5.91 million and -$8.52 million in losses. Loss per share was -$4.93.
| Revenue | 5.91M |
| Gross Profit | 998,516 |
| Operating Income | -13.79M |
| Pretax Income | -24.50M |
| Net Income | -8.52M |
| EBITDA | -13.77M |
| EBIT | -13.79M |
| Loss Per Share | -$4.93 |
Full Income StatementBalance Sheet
The company has $3,678 in cash and $4.00 million in debt, giving a net cash position of -$4.00 million or -$0.83 per share.
| Cash & Cash Equivalents | 3,678 |
| Total Debt | 4.00M |
| Net Cash | -4.00M |
| Net Cash Per Share | -$0.83 |
| Equity (Book Value) | -7.10M |
| Book Value Per Share | -3.38 |
| Working Capital | -6.10M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.82M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.82M |
| FCF Per Share | -$0.80 |
Full Cash Flow StatementMargins
Gross margin is 16.89%, with operating and profit margins of -233.14% and -144.05%.
| Gross Margin | 16.89% |
| Operating Margin | -233.14% |
| Pretax Margin | -144.05% |
| Profit Margin | -144.05% |
| EBITDA Margin | -232.91% |
| EBIT Margin | -233.14% |
| FCF Margin | n/a |